Anika Therapeutics Inc
$20.84
-$0.07 (-0.33%)
$20.75Day Range$21.16
Key Statistics
Market Cap
$279.84M
Shares Outstanding
13.4M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
May 3, 1993
Round Lot
100
Locale
US
Trading Data
Day Open
$20.79
Day High
$21.16
Day Low
$20.75
Volume
50.6K
VWAP
$20.89
Prev Close
$20.91
Transactions
--
Acc. Volume
--
About Anika Therapeutics Inc
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
SURGICAL & MEDICAL INSTRUMENTS & APPARATUSSIC 3841235 employees32 WIGGINS AVENUE, BEDFORD, MA, 01730(781) 457-9000IPO May 3, 1993US / STOCKSActiveWebsite
Identifiers
- CIK
- 0000898437
- Composite FIGI
- BBG000BBKZD8
- Share Class FIGI
- BBG001S609X7
- Ticker Root
- ANIK
- SIC Code
- 3841
About Anika Therapeutics Inc (ANIK) Stock
Anika Therapeutics Inc (ANIK) closed the 2026-09-16 session at $20.84, down 0.33% versus the previous close (-0.07). The stock opened at $20.79 and traded between $20.75 and $21.16 during that session. Session trading volume was 51K shares. The volume-weighted average price (VWAP) is $20.89.
Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.
Anika Therapeutics Inc has a market capitalization of $279.8 million. The company operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS industry classification. ANIK is listed on the XNAS exchange. The company employs approximately 235 people. Anika Therapeutics Inc is headquartered in BEDFORD, MA. The recorded listing date is 1993-05-03.
On this page you can find market ANIK stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector.